Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.645 USD | +2.77% | +0.76% | +1.64% |
05-10 | Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
03-05 | Top Premarket Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.64% | 14.54M | |
+8.84% | 114B | |
+11.43% | 104B | |
-12.65% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-3.02% | 17.89B | |
+7.93% | 14.28B | |
+35.40% | 12.55B |
- Stock Market
- Equities
- EDSA Stock
- News Edesa Biotech, Inc.
- Edesa Biotech, US FDA Agree on EB05 Phase 3 Trial's Primary Endpoint, Population